Dr. Sherwood is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 SW Archer Rd
Gainesville, FL 32610Phone+1 352-846-2112Fax+1 352-273-7402
Education & Training
- University of Manchester Faculty of MedicineClass of 1976
Certifications & Licensure
- FL State Medical License 1986 - 2025
- MD State Medical License 1986 - 2017
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2005-2014
- Top Doctors: Florida Castle Connolly, 2000
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Primary Tube Versus Trabeculectomy Study Start of enrollment: 2008 Apr 01
Publications & Presentations
PubMed
- 7 citationsNeovascular glaucoma after carotid endarterectomy.Quang H Nguyen, Latif M. Hamed, Mark B. Sherwood, Robert L Roseman
Ophthalmic Surgery and Lasers. 1996-10-01 - 153 citationsSix-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure.Mark B. Sherwood, James D. Brandt
Survey of Ophthalmology. 2001-05-01 - 188 citationsLatanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups.Carl B. Camras, Albert Alm, Peter G. Watson, Johan Stjernschantz, H. Aasved
Ophthalmology. 1996-11-01
Press Mentions
- Experiencing Long COVID Symptoms? Here's What You Need to KnowFebruary 25th, 2022
- Today's Health Care Is 'Sick Care,' Leading Naturopathic Doctor SaysAugust 23rd, 2021
- Why Your Immune System May Resemble an Overtaxed Fire Truck—and What You Can Do About ItAugust 6th, 2021
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: